|
Citizen Posts
Getting your Trinity Audio player ready...
|
President Yoweri Kaguta Museveni has commissioned Uganda’s first locally developed anti-tick vaccine at the National Livestock Resources Research Institute (NaLIRRI) at Namulonge, Nansana Municipality, describing it as a lasting solution to tick-borne diseases that have long affected livestock.
The 170 billion-shilling initiative was undertaken by the government of Uganda to address the tick threat to livestock in the country.
Speaking at the launch of the vaccine and a production plant, Museveni said ticks have been a major challenge in cattle-keeping areas such as Sheema, Kajara, and parts of Kashari, where farmers, despite the absence of tsetse flies, continue to suffer heavy losses.
He described ticks as a long-standing setback to Uganda’s livestock sector and emphasized that the new vaccine provides a safer and more durable alternative to acaricides, which he noted are toxic and become less effective over time.
“The cow now kills the tick,” he said, underscoring the innovation behind the vaccine. Museveni also reiterated his commitment to strengthening Uganda’s science sector, proposing tax incentives for scientists similar to those extended to security personnel, in recognition of their role in national development.
He further congratulated the scientists behind the innovation and pledged continued government support. Museveni also confirmed government’s commitment to avail additional 600 billion shillings requested by the National Agricultural Research Organisation to establish the vaccine research hub.
The Minister of Agriculture, Animal Industry and Fisheries, Frank Tumwebaze, welcomed the milestone, revealing that the project dates back to 2022 when scientists first presented their proposal. He commended the President and government for the support that has culminated in the successful development of the vaccine.
The State Minister for Animal Industry, Bright Rwamirama, praised sustained government investment in livestock, noting growth in dairy farming and an increase in livestock numbers. The Director General of NARO, Dr Yonah Baguma, described the launch as both a scientific and economic milestone.
He said the vaccine is expected to protect Uganda’s estimated 16 million cattle while reducing reliance on imported vaccines and acaricides.
He added that the facility has the capacity to produce up to 36 million doses annually, with current production at about three million doses per month. So far, 1.5 million doses have been produced, with demand already emerging from neighboring countries.
Baguma noted that the project has created hundreds of jobs and positions Uganda as a potential regional hub for veterinary vaccine production.
The vaccine, branded NAROVAC-ATV1, is a recombinant product developed using antigens derived from local tick species. It is administered to cattle from one month old, with three initial doses given at day 0, day 30, and day 180, protecting for a full year. Booster doses are administered in subsequent years.
The Executive Director of the National Drug Authority, Dr. David Nahamya, confirmed that the manufacturing plant meets required standards, noting that the authority provided technical oversight throughout the development process.
Farmers involved in early trials have reported positive results, citing reduced tick infestations and lower treatment costs. The vaccine will be retailed at ten thousand shillings per dose to the farmers. Museveni said he will use it to vaccinate his cattle in Rwakitura and Gomba.
Source: By URN
If you have a story in your community or an opinion article, let’s publish it. Send us an email via citizenposts24@gmail.com .Follow our WhatsApp Channel HERE to see more of our stories.
